drugset / Trial / NCT01933321

Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01933321 ↗

Phase 2/3 Completed 14 enrolled Hospital Universitario Dr. Jose E. Gonzalez
NaSingle-groupOpen-labelTreatment

Summary

Autologous cell therapy in patients with ALS can stimulate neuroplasticity, modifying the neurodegenerative process and stops the clinical progression of disease.

Timeline

Start
2012-09
Primary completion
2014-01
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Intrathecal autologous stem cell Cell therapy — Intrathecal